Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of intramuscular PLX-PAD for intermittent claudication
2011-004091-12Phase 2Completed
- Sponsor
- Pluri Inc.
- Start
- Jul 2012
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in arteriosclerosis obliterans and intermittent claudication (IC) comparing PLX-PAD intramuscular injections with Placebo intramuscular injections (2 arms). Primary endpoint: Primary efficacy endpoint. Started Jul 2012; status: completed.
02
Drugs
PLX-PAD
03
Conditions
arteriosclerosis obliteransintermittent claudication (IC)
Beyond the preview
Go deeper on 2011-004091-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004091-12.